BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 16885031)

  • 1. Destruction or potentiation of different prions catalyzed by similar Hsp104 remodeling activities.
    Shorter J; Lindquist S
    Mol Cell; 2006 Aug; 23(3):425-38. PubMed ID: 16885031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion conformers.
    Shorter J; Lindquist S
    Science; 2004 Jun; 304(5678):1793-7. PubMed ID: 15155912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsp104, Hsp70 and Hsp40 interplay regulates formation, growth and elimination of Sup35 prions.
    Shorter J; Lindquist S
    EMBO J; 2008 Oct; 27(20):2712-24. PubMed ID: 18833196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsp104 binds to yeast Sup35 prion fiber but needs other factor(s) to sever it.
    Inoue Y; Taguchi H; Kishimoto A; Yoshida M
    J Biol Chem; 2004 Dec; 279(50):52319-23. PubMed ID: 15448141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic and Structural Insights into the Prion-Disaggregase Activity of Hsp104.
    Sweeny EA; Shorter J
    J Mol Biol; 2016 May; 428(9 Pt B):1870-85. PubMed ID: 26608812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of Hsp104 with yeast prion Sup35 as analyzed by fluorescence cross-correlation spectroscopy.
    Ohta S; Kawai-Noma S; Kitamura A; Pack CG; Kinjo M; Taguchi H
    Biochem Biophys Res Commun; 2013 Dec; 442(1-2):28-32. PubMed ID: 24216111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Hsp104 N-terminal domain enables disaggregase plasticity and potentiation.
    Sweeny EA; Jackrel ME; Go MS; Sochor MA; Razzo BM; DeSantis ME; Gupta K; Shorter J
    Mol Cell; 2015 Mar; 57(5):836-849. PubMed ID: 25620563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsp104-dependent remodeling of prion complexes mediates protein-only inheritance.
    Satpute-Krishnan P; Langseth SX; Serio TR
    PLoS Biol; 2007 Feb; 5(2):e24. PubMed ID: 17253904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The small heat shock protein Hsp31 cooperates with Hsp104 to modulate Sup35 prion aggregation.
    Aslam K; Tsai CJ; Hazbun TR
    Prion; 2016 Nov; 10(6):444-465. PubMed ID: 27690738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prion curing agent guanidinium chloride specifically inhibits ATP hydrolysis by Hsp104.
    Grimminger V; Richter K; Imhof A; Buchner J; Walter S
    J Biol Chem; 2004 Feb; 279(9):7378-83. PubMed ID: 14668331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of pre-existing aggregates in Hsp104-dependent polyglutamine aggregate formation and epigenetic change of yeast prions.
    Kimura Y; Koitabashi S; Kakizuka A; Fujita T
    Genes Cells; 2004 Aug; 9(8):685-96. PubMed ID: 15298677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal domain of yeast Hsp104 chaperone is dispensable for thermotolerance and prion propagation but necessary for curing prions by Hsp104 overexpression.
    Hung GC; Masison DC
    Genetics; 2006 Jun; 173(2):611-20. PubMed ID: 16582428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yeast prion protein New1 can break Sup35 amyloid fibrils into fragments in an ATP-dependent manner.
    Inoue Y; Kawai-Noma S; Koike-Takeshita A; Taguchi H; Yoshida M
    Genes Cells; 2011 May; 16(5):545-56. PubMed ID: 21453424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heat shock protein 104 (Hsp104)-mediated curing of [
    Zhao X; Rodriguez R; Silberman RE; Ahearn JM; Saidha S; Cummins KC; Eisenberg E; Greene LE
    J Biol Chem; 2017 May; 292(21):8630-8641. PubMed ID: 28373280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curing of yeast [PSI+] prion by guanidine inactivation of Hsp104 does not require cell division.
    Wu YX; Greene LE; Masison DC; Eisenberg E
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12789-94. PubMed ID: 16123122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prion and nonprion amyloids: a comparison inspired by the yeast Sup35 protein.
    Kushnirov VV; Vishnevskaya AB; Alexandrov IM; Ter-Avanesyan MD
    Prion; 2007; 1(3):179-84. PubMed ID: 19164899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of the chaperone Hsp104 with yeast Sup35 and mammalian PrP.
    Schirmer EC; Lindquist S
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13932-7. PubMed ID: 9391130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of Hsp104/ClpB inhibition by prion curing Guanidinium hydrochloride.
    Kummer E; Oguchi Y; Seyffer F; Bukau B; Mogk A
    FEBS Lett; 2013 Mar; 587(6):810-7. PubMed ID: 23416293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yeast [PSI+] prion aggregates are formed by small Sup35 polymers fragmented by Hsp104.
    Kryndushkin DS; Alexandrov IM; Ter-Avanesyan MD; Kushnirov VV
    J Biol Chem; 2003 Dec; 278(49):49636-43. PubMed ID: 14507919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temperature dependence of the aggregation kinetics of Sup35 and Ure2p yeast prions.
    Sabaté R; Villar-Piqué A; Espargaró A; Ventura S
    Biomacromolecules; 2012 Feb; 13(2):474-83. PubMed ID: 22176525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.